Abstracts

444 – RV550: IL-15 Superagonist N-803 With ART in Acute HIV Infection Enhances T and NK Cell Proliferation

Background In the RV550 clinical trial, we hypothesized that IL-15 superagonist N-803 administration with ART during acute HIV infection (AHI) would limit HIV reservoir establishment and persistence. Here, we characterized the effects of N-803 on T cells and NK cells in peripheral blood (PBMC) and lymph nodes (LN). Methods Participants with AHI (Fiebig I-IV) were…

448 – Elucidating the Role of Natural Killer Cells in Antibody Breadth During HIV Infection

Background Natural Killer (NK) cells are underappreciated regulators of the antibody response to infection. In mice, NK cells can kill T follicular helper cells which decreases somatic hypermutation and vaccine response. In the context of HIV, dysfunctional NK cells are associated with broadly neutralizing antibodies. Understanding the temporal immune factors that influence breadth is an…

445 – NF-kappa-B Signaling in Natural Killer Cells Predicts Post-Treatment HIV Control

Background For most people with HIV (PWH) on antiretroviral therapy (ART), cessation of ART results in rapid rebound of viremia. However, in rare individuals, called post-treatment controllers (PTCs), HIV is controlled through poorly understood mechanisms. The objective of this study was to leverage multiomics single-cell sequencing approaches to assess the extent to which the transcriptomic and epigenetic features…

402 – The Soft Escape: HIV Alters Host Cell Cytoskeleton as a Mechanism of Resistance to CTL Killing

Background HIV latency enables viral persistence during ART, but CTL pressure continues to shape the HIV reservoir. CD4+ T-cells exhibit varying susceptibilities to CTL attack, potentially leading to the selection of CTL-resistant HIV reservoir-harboring cells. Effective CTL-mediated killing requires the formation of an immune synapse through biophysical forces, with CTLs being more efficient at eliminating…

419 – In Nonsuppressible Viremia, HIV Env Can Maintain Resistance to Autologous Neutralizing Antibodies

Background Nonsuppressible viremia (NSV) represent a subset of individuals with persistent low-level viremia due to a hyperactive HIV reservoir. Little is known about whether persistent antigenemia during NSV can induce a stronger immune response. Autologous neutralizing antibodies (aNAb) represent a key adaptive immune response for viral control and HIV rebound during treatment interruption has been…

482 – Herpes Zoster Reactivation in a Cohort of People Living With HIV Vaccinated With Recombinant Vaccine

Background People living with HIV (PLWH) have a higher risk of herpes zoster (HZ) reactivation and postherpetic neuralgia (PHN) compared to general population. Our study aims to evaluate prevalence of HZ reactivation and PHN after vaccination with recombinant vaccine in a population living with HIV, and to identify risk factors associated with recurrence. Methods We…

455 – Cannabidiol Has Sex-Dependent Anti-Inflammatory Effects in Long-Term Suppressed HIV-1 Adults

Background People with long-term HIV-1 suppression (PWH) suffer from inflammaging, characterized by chronic inflammation and immunosenescence. As cannabis smokers display immune beneficial effects such as lower inflammation levels we decided to investigate the anti-inflammatory properties of one of its major component, the cannabidiol (CBD) under a full-spectrum oil, on PWH. Methods Within the double-blind, randomized,…